Abstract. The work studies ZrO 2 (Me x O y )-based porous ceramics produced from the powders consisting of hollow spherical particles. It was shown that the structure is represented by a cellular framework with bimodal porosity consisting of sphere-like large pores and pores that were not filled with the powder particles during the compaction. For such ceramics, the increase of pore volume is accompanied by the increased strain in an elastic area. It was also shown that the porous ZrO 2 ceramics had no acute or chronic cytotoxicity. At the same time, ceramics possess the following osteoconductive properties: adhesion support, spreading, proliferation and osteogenic differentiation of MSCs.
INTRODUCTION
Porous ceramic materials have been successfully used in various fields, including heat-insulating construction materials, because they are durable, corrosion resistant and they possess stable thermal features [1] [2] [3] . Porous ceramics are also a promising material for medical use in the field of traumatology and orthopedics for critical sized bone defect recovery. Thus porous ceramics can act both as osteoplastic material and as 3D scaffold for tissueengineered bone equivalent modeling [4] .
Ceramics based on partially stabilized zirconium are the most interesting among the variety of ceramic materials due to their inherent high transformation toughening. It is known that the characteristics are determined by the quality of source ceramic powder (particle shape, particle size distribution), the compaction conditions, sintering mode, features of each phase and how these phases, including pores, are arranged in relation to each other. The most important factor in the successful application of materials is understanding the features of their structure and their behavior under mechanical impact.
The aim of a paper is to examine the pore structure of ZrO 2 (Me x O y ) ceramics and its biocompatibility with multipotent stromal cells (mesenchymal stem cells, MSCs) by in vitro assays. 
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MATERIALS AND EXPERIMENTAL PROCEDURE
The materials for the study were ceramics obtained from ZrO 2 (MgO) and ZrO 2 (Y 2 O 3 ) powders produced by liquid-phase decomposition of precursors synthesized in high-frequency discharge plasma (the plasmachemical method).
Porous ceramic ZrO 2 (MgO) and ZrO 2 (Y 2 O 3 ) samples were prepared by compacting and subsequent sintering of compacts at the homologous temperatures ranging from 0.63 to 0.56 during the isothermal soaking for 1 to 5 hours. The porosity of ZrO 2 (MgO) and ZrO 2 (Y 2 O 3 ) ceramics ranged from 15% to around 45% and from 30% to 80%, respectively. X-ray studies were carried out using a diffractometer with a CuK source of filtered radiation. The studies on the ceramic structure were carried out using Philips SEM 515 scanning electron microscope.
To assess the biocompatibility of porous ceramics, the adipose-derived MSCs have been used. MSCs were isolated by enzymatic method and cultured in DMEM:F12 supplemented with 2 mM L-glutamine and 10% FBS ("Sigma", USA) and incubated with the use of Cell IQ® v2 MLF integrated continuous live cell imaging and analysis platform (CM Technologies). The third passage MSCs have been used for the experiments. Preliminarily, MSC culture compliance with minimal criteria was made for phenotype (flow cytometry) and differentiation potential (differentiation assays for adipocytes and osteoblasts) [5] . Prior to seeding over the implants, cell viability in suspension was assessed by Trypan blue staining. [6] To assess the cytotoxicity of the implants and the viability of cultured MSCs over their surfaces, cell combined double staining with fluorescein diacetate (FDA) and propidium iodide (PI) 24h after inoculation and 7 days after culturing was made [7] . Assessment of cytotoxicity was performed using Axio Observer A1 inverted fluorescent microscope (Carl Zeiss, Germany). For the further biocompatibility assessment, the MSC osteogenic differentiation assay was performed according to standard protocols [8] . MSCs were cultured in implants or over its surface for 14 days, followed by detection of alkaline phosphatase activity using the BCIP/NBT substrate (Sigma, USA) [9] .
RESULTS AND DISCUSSION
Powders. Figure 1 The cells were nearly spherical and the cell size exceeded many-fold the thickness of walls that were represented by a single-layer stack of ZrO 2 grains. The pore size distribution was bimodal. The first maximum was formed by equiparticle pores, the voids that were not filled with powder particles during the compaction, and the second maximum was conditioned by the larger pores with a shape close to spherical. The plots presented in Fig. 2b demonstrates the dependence of the average size of equiparticle and large spherical pores on the porosity in ZrO 2 (MgO) and ZrO 2 (Y 2 O 3 ) ceramics. It is clear that the increase of pore volume in the material from about 30 to 80% achieved by reducing the sintering temperature of the samples was accompanied by the increase of the average size of large pores from 2 to 6 microns. Changing the porosity of the material had practically no effect on the average size of equiparticle pores having the average size of 0.5 microns. It can be assumed that the presence of large pores close to a spherical shape in the ceramics is conditioned by the presence of hollow spherical particles in the source powders, since their average size is commensurate with the average size of large pores occurring in the sintered material.
Biocompatibility: cytotoxicity and osteogenic differentiation of MSCs/ Cultured adipose tissue-derived MSCs used for the preliminary assessment of the biocompatibility of porous ceramic implants had the capacity to differentiate in adipogenic and osteogenic directions and had the following phenotype: CD73+ CD90+ CD105+ and CD34-CD45-. Combined staining of FDA/PI cells cultured on the surface or in the implants showed no cytotoxicity of porous ZrO 2 ceramics (Fig. 3) . The results of the cell viability evaluation in suspension with the use of Trypan blue staining before seeding and 24h after culturing on implants by staining with FDA/PI exhibited similar values (suspension, Trypan blue, 96.42% ± 1.8% viable cells; implant, FDA/PI, 93.78% ± 2.15%). Microscopic observation showed that MSCs 24h after seeding adhered to the surface of the implant and generated intensive and uniform green FDA stain in the absence of red PI stain, which indicates a high metabolic activity of the cells and the integrity of their membrane. At the same time the cells had different spreading degree due to the rough surface of the implant through its physical structure (the presence of pores and composition of hollow particles of a spherical shape and a large number of units having no regular form). Cell viability after 7 days of culturing with porous ZrO 2 ceramic implants was 92.56% ± 1.44%, which is comparable to cell viability before seeding and after 24h culturing with implants (difference is not statistically significant). Moreover, after 7 days of MSC culturing on the surface of porous ZrO 2 ceramics, the formation of cell clusters due to their proliferation was noted. Thus, porous ZrO 2 ceramic implants do not have the acute and chronic cytotoxicity. Detection of alkaline phosphatase activity with use of BCIP/NBT substrate showed that cultured MSCs on the porous surface of ZrO 2 ceramic implant retain their ability for osteogenic differentiation (Fig. 4) . Based on the results of the osteogenic differentiation of MSCs, we can conclude that porous ZrO 2 ceramic implants possess osteoconductive properties.
CONCLUSIONS
It was elucidated that the structure of ZrO 2 (Me x O y ) ceramics made of powders consisting of hollow spherical particles with the porosity of 30% is represented by a cellular framework with the bimodal porosity, formed by large pores with the shape close to spherical and pores that were not filled with the powder particles during the compaction. It was found that ZrO 2 (Me x O y ) ceramics with bimodal pore size distribution at the porosity exceeding 30% demonstrate the micromechanical instability during the compaction, which is caused by the reversible deformation of the cellular elements. For the cases of such ceramics the increase of pore volume is accompanied by the increase of strain in the elastic area. It was also shown that the porous ZrO 2 ceramics had no acute or chronic cytotoxicity. At the same time, the porous ZrO 2 ceramics possess the osteoconductive properties: adhesion support, spreading, proliferation and osteogenic differentiation of MSCs.
